Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

@article{Li2020EarlyTD,
  title={Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia},
  author={Qun Li and X. Guan and Peng Wu and Xiaoye Wang and Lei Zhou and Y. Tong and R. Ren and K. Leung and E. Lau and J. Wong and X. Xing and N. Xiang and Y. Wu and Changhong Li and Qi Chen and D. Li and Tian Liu and J. Zhao and Man-shi Li and W. Tu and Chuding Chen and Lian-mei Jin and Rui Yang and Q. Wang and Suhua Zhou and R. Wang and H. Liu and Yingbo Luo and Y. Liu and G. Shao and Huan Li and Z. Tao and Y. Yang and Zhiqiang Deng and B. Liu and Zhitao Ma and Yanping Zhang and G. Shi and T. Lam and Joseph T K Wu and G. Gao and B. Cowling and Bo Yang and G. Leung and Zijian Feng},
  journal={The New England Journal of Medicine},
  year={2020},
  volume={382},
  pages={1199 - 1207}
}
Abstract Background The initial cases of novel coronavirus (2019-nCoV)–infected pneumonia (NCIP) occurred in Wuhan, Hubei Province, China, in December 2019 and January 2020. We analyzed data on the first 425 confirmed cases in Wuhan to determine the epidemiologic characteristics of NCIP. Methods We collected information on demographic characteristics, exposure history, and illness timelines of laboratory-confirmed cases of NCIP that had been reported by January 22, 2020. We described… Expand

Paper Mentions

Interventional Clinical Trial
SARS-CoV-2 infection mainly leads to interstitial pneumonia. The patients with low immunity have more serious conditions. At present, there is no specific drug/therapy available for… Expand
ConditionsCOVID-19
InterventionBiological
Interventional Clinical Trial
Blinded, multicenter, placebo-controlled, randomized clinical trial evaluating lopinavir/ritonavir vs placebo in early outpatient treatment of adults with COVID-19  
ConditionsCOVID-19
InterventionDrug, Other
Observational Clinical Trial
The Respiratory infection COVID-19, due to a new coronavirus, SARS-CoV2, appeared in December 2019 in several people who attended the wildlife market in Wuhan, Hubei Province, China… Expand
ConditionsCovid19, Influenza -Like Illness
InterventionDiagnostic Test
Interventional Clinical Trial
The purpose of this study is to test the safety and efficacy of convalescent donor plasma to treat COVID-19 in hospitalized adults in a randomized, placebo-controlled setting. The… Expand
ConditionsCoronavirus, COVID-19, SARS-CoV-2
InterventionBiological
Epidemiological characteristics and the entire evolution of coronavirus disease 2019 in Wuhan, China
TLDR
The results indicate that the mortality and proportion of severe and critical cases gradually decreased over time, and critical and dead cases are more incline to be older individuals. Expand
Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China
TLDR
Time-varying production number of NCP indicates that rigorous control measures taken by governments are effective across China, and persistent efforts are needed to be taken for reducing instantaneous reproduction number below one. Expand
Phase adjusted estimation of the number of 2019 novel coronavirus cases in Wuhan, China
TLDR
An outbreak of clusters of viral pneumonia due to a novel coronavirus (2019-nCoV / SARS-CoV-2) happened in Wuhan, Hubei Province in China in December 2019 and the estimated number of infections would reach the peak in February 2020, regardless of the occurrence of the peak. Expand
2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies
TLDR
According to the current status, blocking transmission, isolation, protection, and alternative medication are the urgent management strategies against 2019-nCoV. Expand
Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China
TLDR
Regardless of the occurrence of the peak, the currently strict measures in Wuhan should be continuously implemented and necessary strict public health measures should be applied in other locations in China with high number of COVID-19 cases in order to reduce R t to an ideal level and control the infection. Expand
Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study
TLDR
The strict containment measures and movement restrictions in place may contribute to the interruption of local COVID-19 transmission outside Hubei Province, and the shorter serial interval estimated here implies that transmissibility is not as high as initial estimates suggested. Expand
Transmission of corona virus disease 2019 during the incubation period may lead to a quarantine loophole
TLDR
The results indicated the transmission of COVID-9 occurs among close contacts during the incubation period, which may lead to a quarantine loophole and strong and effective countermeasures should be implemented to prevent or mitigate asymptomatic transmission during the hatched period in populations at high risk. Expand
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study
  • Juanjuan Zhang, M. Litvinova, +21 authors Hongjie Yu
  • Medicine, Geography
  • The Lancet Infectious Diseases
  • 2020
TLDR
The findings indicate that strict containment, movement restrictions, and increased awareness of the population have contributed to interrupt transmission of SARS-CoV-2 outside Hubei, and an early peak of infectiousness, with possible transmission before the onset of symptoms is suggested. Expand
Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China
TLDR
Considerable countermeasures have effectively controlled the Covid-19 outbreak in Wuhan, China, and special efforts are needed to protect vulnerable populations, including healthcare workers, elderly and children. Expand
Epidemiological Trends of Coronavirus Disease 2019 in China
TLDR
The COVID-19 epidemic has been primarily contained in China, and the battle against this epidemic in China has provided valuable experiences for the rest of the world. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 29 REFERENCES
Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020
  • Peng Wu, Xinxin Hao, +5 authors G. Leung
  • Medicine
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2020
TLDR
A novel coronavirus (2019-nCoV) causing severe acute respiratory disease emerged recently in Wuhan, China and a risk of fatality among hospitalised cases is estimated at 14% (95% confidence interval: 3.9–32%). Expand
Coronavirus pandemic: A predictive analysis of the peak outbreak epidemic in South Africa, Turkey, and Brazil
TLDR
The investigated model allows us to predict the spread of COID-19 in South Africa, Turkey, and Brazil and the influence of the isolation of the infected persons on thespread of COVID-19 disease. Expand
A Novel Coronavirus from Patients with Pneumonia in China, 2019
TLDR
Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans. Expand
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
TLDR
The findings are consistent with person-to-person transmission of this novel coronavirus in hospital and family settings, and the reports of infected travellers in other geographical regions. Expand
Use of National Pneumonia Surveillance to Describe Influenza A(H7N9) Virus Epidemiology, China, 2004–2013
TLDR
The absolute number and the proportion of PUE cases confirmed to be A(H7N9) declined after live-poultry market closures, indicating that market closures might have positively affected outbreak control and in China, PUE surveillance needs to be improved. Expand
Coronavirus Infections-More Than Just the Common Cold.
TLDR
Yet another pathogenic HCoV, 2019 novel coronavirus (2019-nCoV), was recognized in Wuhan, China, and has caused serious illness and death, and the ultimate scope and effect of this outbreak is unclear at present. Expand
COVID-19: molecular diagnostics overview
TLDR
The molecular overview on the SARS-CoV-2 virus is provided, tremendous efforts that have been made to develop a rapid confirmatory diagnostic test for COVID-19 are summarized and the diagnostic performances of the available tests are analyzed. Expand
Impact of coronavirus pandemic crisis in endoscopic clinical practice: Results from a national survey in Brazil
TLDR
Based on this nationwide survey with almost 1,000 respondents, the COVID-19 pandemic substantially reduced the activity of endoscopy units in private and public settings and the pandemic increased awareness of PPE use, but its availability was not universal and 1 % of the respondents became infected with CO VID-19, allegedly due to exposure during endoscopic procedures. Expand
How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count
TLDR
An alternative approach to maintaining quantitative assessment of the epidemic is proposed, combining illness surveillance for defi ned but non-specifi c syndromes such as acute respiratory illness or infl uenza-like illness with laboratory testing for pandemic H1N1 in a subset of cases. Expand
SARS and MERS: recent insights into emerging coronaviruses
TLDR
The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 marked the second introduction of a highly pathogenic coronav virus into the human population in the twenty-first century, and the current state of development of measures to combat emerging coronaviruses is discussed. Expand
...
1
2
3
...